Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors.
Krista Y ChenAleksandra PopovicDavid HsiehchenMarina BarettiPaige GriffithRanjan BistaAzarakhsh BaghdadiIhab R KamelSanford M SimonRachael D MiglerMark YarchoanPublished in: Cancers (2022)
ICI therapy has modest clinical activity in FLC, and novel therapeutic combinations are needed.